# Interspecies scaling of suprachoroidal drug delivery using ocular geometry and drug physicochemical properties

**Authors:** Madhoosudan A. Patil, Brock A. Matter, Cleildo Santana, Uday B. Kompella

PMC · DOI: 10.1038/s41598-025-34631-x · Scientific Reports · 2026-01-16

## TL;DR

This study examines how drug delivery to the retina and vitreous humor varies across species and drug properties, finding that delivery is influenced by eye size and drug characteristics.

## Contribution

The paper introduces a unified predictive model for suprachoroidal drug delivery that incorporates eye diameter and drug physicochemical properties across multiple species.

## Key findings

- Drug concentrations in the retina were higher than in the vitreous humor across all species.
- A predictive equation incorporating eye diameter and drug properties explained 74% of retinal and 93% of vitreous concentration variance.
- Drug delivery decreased with increasing eye diameter (rabbit > porcine > bovine).

## Abstract

Excised rabbit, porcine, and bovine eyes were injected in the suprachoroidal space with a cassette of 27 drugs, including 10 beta-blockers, 8 NSAIDs, and 9 corticosteroids, spanning a lipophilicity range (LogD7.4: −4.18 to 4.70). Drug concentrations in retina and vitreous humor were quantified by LC-MS/MS on both injected and non-injected sides. Most drugs were detected in both tissues, with higher concentrations on the injected side (0.04–3.69 fraction dose or FD/g) compared to the non-injected side (0.00–0.74 FD/g), after excluding eight outliers (drug–prodrug pairs and unstable drugs). Total retinal concentrations (0.07–1.88 FD/g) exceeded vitreous concentrations (0.02–0.40 FD/g). Across species, delivery decreased with eye diameter (rabbit > porcine > bovine). For individual species, multiple linear regression explained 70–83% of variance in retinal concentrations and 45–62% in vitreous concentrations using drug physicochemical properties. A unified equation incorporating 1/d² (d is eye diameter in cm), lipophilicity (LogD7.4), molar solubility (LogS), and total polar surface area (TPSA) predicted concentrations in all species for a given tissue, explaining 74% of retinal and 93% of vitreous variance. Retinal delivery scaled for all species: Log FD/g = -1.121 + 0.255*LogD7.4 + 0.106*LogS + 0.004*TPSA + 0.395*1/d2. Vitreous humor delivery scaled for all species: Log FD/g = -1.898–0.047*LogD7.4 − 0.051*LogS + 0.001*TPSA + 0.833*1/d2. While this study evaluated static barriers, in vivo delivery is expected to be lower due to dynamic clearance mechanisms.

The online version contains supplementary material available at 10.1038/s41598-025-34631-x.

## Full-text entities

- **Genes:** VEGFA (vascular endothelial growth factor A) [NCBI Gene 281572] {aka VEGF, VEGF-A, VPF, eVEGF120, eVEGF164}
- **Diseases:** uveitis (MESH:D014605), macular edema (MESH:D008269), eye diseases (MESH:D005128)
- **Chemicals:** potassium phosphate (MESH:C013216), DMSO (MESH:D004121), calcium chloride (MESH:D002122), carbon (MESH:D002244), oxprenolol hydrochloride (MESH:D010096), mannitol (MESH:D008353), indoprofen (MESH:D007216), ice (MESH:D007053), dexamethasone disodium phosphate (MESH:C004180), alprenolol hydrochloride (MESH:D000526), fluorescein (MESH:D019793), halogen (MESH:D006219), prednisone (MESH:D011241), atenolol (MESH:D001262), celecoxib (MESH:D000068579), timolol maleate (MESH:D013999), ketoprofen (MESH:D007660), difluprednate (MESH:C015808), bromine (MESH:D001966), bromfenac (MESH:C053083), potassium chloride (MESH:D011189), water (MESH:D014867), sodium chloride (MESH:D012965), pindolol (MESH:D010869), Hydrogen (MESH:D006859), sotalol (MESH:D013015), prednisolone 21-acetate (MESH:C009935), TA (MESH:D014222), nitrogen (MESH:D009584), prednisolone (MESH:D011239), nepafenac (MESH:C414203), budesonide (MESH:D019819), tolmetin sodium dihydrate (MESH:D014046), fluocinolone acetonide (MESH:D005446), NaF (MESH:D012969), rhodamine-6G (MESH:C026188), sodium phosphate (MESH:C018279), formic acid (MESH:C030544), mefenamic acid (MESH:D008528), methanol (MESH:D000432), nadolol (MESH:D009248), Acetonitrile (MESH:C032159), magnesium sulfate heptahydrate (MESH:D008278), triamcinolone (MESH:D014221), nitric oxide (MESH:D009569), CH2O2 (-), flupirtine (MESH:C034161), triamcinolone hexacetonide (MESH:C005900), dexamethasone (MESH:D003907), betaxolol hydrochloride (MESH:D015784), metoprolol tartrate (MESH:D008790), naproxen (MESH:D009288), propranolol hydrochloride (MESH:D011433)
- **Species:** Bos taurus (bovine, species) [taxon 9913], Sus scrofa (pig, species) [taxon 9823], Homo sapiens (human, species) [taxon 9606], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12864957/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12864957/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12864957/full.md

---
Source: https://tomesphere.com/paper/PMC12864957